Delving Into the Patterns of Patient Engagement and Trends in Participation Within Recurrent Ovarian Cancer Clinical Trials
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 500
- 试验地点
- 1
- 主要终点
- Number of patients who decide to participate in a recurrent ovarian cancer clinical trial
研究概览
简要总结
Clinical trials, with a particular focus on recurrent ovarian cancer, play a crucial role in assessing the safety and efficacy of novel treatments for this condition. These trials serve as essential tools to determine whether new medications outperform traditional therapies, providing substantial evidence to support their widespread adoption.
By actively participating in recurrent ovarian cancer observational study serves pivotal role in expanding the boundaries of medical knowledge and advancing the quality of care provided to those enduring the same condition.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Crossover
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Aged ≥ 18 years old
- •Able to comprehend the investigational nature of the protocol and provide informed consent
- •Diagnosis of recurrent ovarian cancer
排除标准
- •No diagnosis of recurrent ovarian cancer confirmed
- •Inability to perform regular electronic reporting
- •Patient does not understand, sign, and return consent form
结局指标
主要结局
Number of patients who decide to participate in a recurrent ovarian cancer clinical trial
时间窗: 3 months
Rate of patients who remain in recurrent ovarian cancer clinical research to trial completion
时间窗: 12 months
次要结局
未报告次要终点